| The role of proteomics in biomarker development for improved patient diagnosis and clinical decision making in prostate cancer CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong, SR Pennington Diagnostics 6 (3), 27, 2016 | 27 | 2016 |
| Pro-inflammatory stimulation of monocytes by ANCA Is linked to changes in cellular metabolism EC O'Brien, CA White, J Wyse, E Leacy, RK Porter, MA Little, FB Hickey Frontiers in Medicine 7, 553, 2020 | 9 | 2020 |
| Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism E Leacy, G Brady, MA Little Rheumatology 59 (Supplement_3), iii33-iii41, 2020 | 9 | 2020 |
| Study protocol for the St james's hospital, tallaght university hospital, trinity college Dublin allied researchers'(STTAR) bioresource for COVID-19 L O'Doherty, SH Phelan, N Wood, S O'Brien, J Sui, C Mangan, F Howley, ... HRB Open Research 5, 2022 | 6 | 2022 |
| Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis D Dooley, MM van Timmeren, VP O’Reilly, G Brady, EC O’Brien, ... Kidney International 94 (5), 926-936, 2018 | 5 | 2018 |
| Long-term follow-up of Pi* ZZ alpha-1 antitrypsin deficient patients receiving intravenous alpha-1 antitrypsin augmentation therapy S Roche, DD Fraughen, M Herron, R Heeney, L Alhaddah, E Leacy, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Family Screening in Severe Alpha-1 Antitrypsin Deficiency-Too Little, Too Late? An Argument for Newborn Screening S Roche, D Fraughen, RC Heeney, M Herron, L Alhaddah, E Leacy, ... A41. EMERGING CLINICAL AND TRANSLATIONAL RESEARCH IN COPD AND ALPHA-1 …, 2023 | 1 | 2023 |
| Optimal LC-MS metabolomic profiling reveals emergent changes to monocyte metabolism in response to lipopolysaccharide E Leacy, I Batten, L Sanelli, M McElheron, G Brady, MA Little, H Khouri Frontiers in Immunology 14, 1116760, 2023 | 1 | 2023 |
| Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination EJ Leacy, JW Teh, AM O’Rourke, G Brady, S Gargan, N Conlon, J Scott, ... International Journal of Molecular Sciences 25 (10), 5239, 2024 | | 2024 |
| Optimizing Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency M Herron, SM Roche, LP Kanchi, E Leacy, RC Heeney, TP Carroll, ... B50. EMERGING RESEARCH IN ALPHA-1-ANTITRYPSIN DEFICIENCY, A3793-A3793, 2024 | | 2024 |
| The Protease Anti-protease Balance in Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency M Herron, SM Roche, LP Kanchi, E Leacy, RC Heeney, TP Carroll, ... C24. CLINICAL, BIOLOGIC, AND RADIOLOGIC MARKERS OF KEY OUTCOMES AND …, 2024 | | 2024 |
| Cortisol on the Clock: Systemic Circadian Disruption in Severe Alpha-1 Antitrypsin Deficiency E Leacy, L Alhaddah, D Fraughen, M Herron, RC Heeney, SM Roche, ... B50. EMERGING RESEARCH IN ALPHA-1-ANTITRYPSIN DEFICIENCY, A3795-A3795, 2024 | | 2024 |
| Long-term Follow-up of Pi [asterisk] ZZ Alpha-1 Antitrypsin Deficient Patients Receiving Intravenous Alpha-1 Antitrypsin Augmentation Therapy SM Roche, D Fraughen, M Herron, RC Heeney, L Logan, E Leacy, ... B50. EMERGING RESEARCH IN ALPHA-1-ANTITRYPSIN DEFICIENCY, A3787-A3787, 2024 | | 2024 |
| Family Screening in ZZ Alpha-1 Antitrypsin Deficiency-Exposing the Hidden Burden of Liver Disease SM Roche, D Fraughen, M Herron, RC Heeney, E Farrell, LP Kanchi, ... B50. EMERGING RESEARCH IN ALPHA-1-ANTITRYPSIN DEFICIENCY, A3788-A3788, 2024 | | 2024 |
| Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival but is decoupled from FEV1 decline D Fraughen, AJ Ghosh, BD Hobbs, T Meischl, NA Sievi, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Optimising research bronchoalveolar lavage in COPD and alpha-1 antitrypsin deficiency M Herron, D Fraughen, S Roche, L Kanchi, E Leacy, L Alhaddah, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| PiSS Alpha-1 Antitrypsin Deficiency: A Clinical Risk Variant? D Fraughen, TP Carroll, RC Heeney, G Kelly, M Herron, S Roche, ... A41. EMERGING CLINICAL AND TRANSLATIONAL RESEARCH IN COPD AND ALPHA-1 …, 2023 | | 2023 |
| Circadian Protein Localisation in Monocytes of Severe Alpha 1 Antitrypsin Deficiency L Alhaddah, D Fraughen, RC Heeney, E Leacy, M Herron, TP Carroll, ... C33. ADVANCES AND UNSOLVED MYSTERIES IN COPD, A4793-A4793, 2023 | | 2023 |
| ADAM-17 Concentration Is Increased in Severe Alpha-1-Antitrypsin Deficiency E Leacy, D Proceviat, L Alhaddah, A Sharma, Y He, CM Annie, ... C70. COPD (AND LUNG CANCER) CLINICAL AND TRANSLATIONAL STUDIES, A5738-A5738, 2023 | | 2023 |
| Monocyte Subsets and Their Mitochondrial Dynamics Are Disrupted in Alpha-1-Antitrypsin Deficiency E Leacy, M Herron, L Alhaddah, MP Murphy, A Curtis, NG Mcelvaney C69. PRECLINICAL COPD MODELS: IN VITRO, EX VIVO, IN VIVO, A5710-A5710, 2023 | | 2023 |
Mark A LittleTrinity College Dublin在 tcd.ie 的电子邮件经过验证
Mark A LittleTrinity College Dublin在 tcd.ie 的电子邮件经过验证
Gareth BradyAssistant Professor在 tcd.ie 的电子邮件经过验证
Eóin C. O'BrienTrinity College Dublin在 tcd.ie 的电子邮件经过验证